ARCBEST CORP (ARCB)

US03937C1053 - Common Stock

94.13  -3.45 (-3.54%)

After market: 94.13 0 (0%)

Fundamental Rating

6

Overall ARCB gets a fundamental rating of 6 out of 10. We evaluated ARCB against 37 industry peers in the Ground Transportation industry. Both the health and profitability get an excellent rating, making ARCB a very profitable company, without any liquidiy or solvency issues. ARCB has a valuation in line with the averages, but it does not seem to be growing.



7

1. Profitability

1.1 Basic Checks

In the past year ARCB was profitable.
ARCB had a positive operating cash flow in the past year.
Each year in the past 5 years ARCB has been profitable.
ARCB had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

ARCB has a Return On Assets of 8.02%. This is in the better half of the industry: ARCB outperforms 70.27% of its industry peers.
With a Return On Equity value of 14.82%, ARCB perfoms like the industry average, outperforming 59.46% of the companies in the same industry.
The Return On Invested Capital of ARCB (12.10%) is better than 86.49% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ARCB is in line with the industry average of 11.94%.
Industry RankSector Rank
ROA 8.02%
ROE 14.82%
ROIC 12.1%
ROA(3y)9.98%
ROA(5y)7.27%
ROE(3y)21.54%
ROE(5y)15.69%
ROIC(3y)13.45%
ROIC(5y)10.27%

1.3 Margins

With a Profit Margin value of 4.54%, ARCB perfoms like the industry average, outperforming 51.35% of the companies in the same industry.
In the last couple of years the Profit Margin of ARCB has grown nicely.
ARCB has a Operating Margin of 6.53%. This is comparable to the rest of the industry: ARCB outperforms 51.35% of its industry peers.
ARCB's Operating Margin has been stable in the last couple of years.
The Gross Margin of ARCB (85.74%) is better than 97.30% of its industry peers.
In the last couple of years the Gross Margin of ARCB has grown nicely.
Industry RankSector Rank
OM 6.53%
PM (TTM) 4.54%
GM 85.74%
OM growth 3Y14.12%
OM growth 5Y0.46%
PM growth 3Y22.21%
PM growth 5Y15.27%
GM growth 3Y2.85%
GM growth 5Y1.63%

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ARCB is creating some value.
Compared to 1 year ago, ARCB has less shares outstanding
The number of shares outstanding for ARCB has been reduced compared to 5 years ago.
The debt/assets ratio for ARCB has been reduced compared to a year ago.

2.2 Solvency

ARCB has an Altman-Z score of 4.18. This indicates that ARCB is financially healthy and has little risk of bankruptcy at the moment.
ARCB has a Altman-Z score of 4.18. This is amongst the best in the industry. ARCB outperforms 83.78% of its industry peers.
The Debt to FCF ratio of ARCB is 2.22, which is a good value as it means it would take ARCB, 2.22 years of fcf income to pay off all of its debts.
ARCB has a better Debt to FCF ratio (2.22) than 83.78% of its industry peers.
ARCB has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
ARCB's Debt to Equity ratio of 0.09 is fine compared to the rest of the industry. ARCB outperforms 78.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 2.22
Altman-Z 4.18
ROIC/WACC1.41
WACC8.55%

2.3 Liquidity

ARCB has a Current Ratio of 1.04. This is a normal value and indicates that ARCB is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of ARCB (1.04) is comparable to the rest of the industry.
ARCB has a Quick Ratio of 1.04. This is a normal value and indicates that ARCB is financially healthy and should not expect problems in meeting its short term obligations.
ARCB has a Quick ratio of 1.04. This is comparable to the rest of the industry: ARCB outperforms 45.95% of its industry peers.
Industry RankSector Rank
Current Ratio 1.04
Quick Ratio 1.04

3

3. Growth

3.1 Past

The earnings per share for ARCB have decreased by -5.71% in the last year.
Measured over the past years, ARCB shows a quite strong growth in Earnings Per Share. The EPS has been growing by 15.40% on average per year.
The Revenue has decreased by -6.88% in the past year.
The Revenue has been growing slightly by 7.43% on average over the past years.
EPS 1Y (TTM)-5.71%
EPS 3Y34.87%
EPS 5Y15.4%
EPS Q2Q%-29%
Revenue 1Y (TTM)-6.88%
Revenue growth 3Y14.62%
Revenue growth 5Y7.43%
Sales Q2Q%-5.78%

3.2 Future

The Earnings Per Share is expected to grow by 11.25% on average over the next years. This is quite good.
ARCB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.08% yearly.
EPS Next Y-23.45%
EPS Next 2Y0.48%
EPS Next 3Y11.25%
EPS Next 5YN/A
Revenue Next Year-5.47%
Revenue Next 2Y-0.79%
Revenue Next 3Y2.08%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 12.67, the valuation of ARCB can be described as correct.
ARCB's Price/Earnings ratio is rather cheap when compared to the industry. ARCB is cheaper than 89.19% of the companies in the same industry.
ARCB is valuated cheaply when we compare the Price/Earnings ratio to 27.20, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 11.80, the valuation of ARCB can be described as reasonable.
Based on the Price/Forward Earnings ratio, ARCB is valued cheaper than 83.78% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of ARCB to the average of the S&P500 Index (23.73), we can say ARCB is valued rather cheaply.
Industry RankSector Rank
PE 12.67
Fwd PE 11.8

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ARCB is valued cheaply inside the industry as 97.30% of the companies are valued more expensively.
ARCB's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ARCB is cheaper than 75.68% of the companies in the same industry.
Industry RankSector Rank
P/FCF 27.15
EV/EBITDA 5.07

4.3 Compensation for Growth

ARCB has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.82
EPS Next 2Y0.48%
EPS Next 3Y11.25%

6

5. Dividend

5.1 Amount

ARCB has a yearly dividend return of 0.49%, which is pretty low.
Compared to an average industry Dividend Yield of 1.31, ARCB has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.36, ARCB's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.49%

5.2 History

On average, the dividend of ARCB grows each year by 8.58%, which is quite nice.
ARCB has paid a dividend for at least 10 years, which is a reliable track record.
ARCB has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)8.58%
Div Incr Years3
Div Non Decr Years14

5.3 Sustainability

5.85% of the earnings are spent on dividend by ARCB. This is a low number and sustainable payout ratio.
The dividend of ARCB is growing, but earnings are growing more, so the dividend growth is sustainable.
DP5.85%
EPS Next 2Y0.48%
EPS Next 3Y11.25%

ARCBEST CORP

NASDAQ:ARCB (12/20/2024, 8:00:00 PM)

After market: 94.13 0 (0%)

94.13

-3.45 (-3.54%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryGround Transportation
Earnings (Last)11-01 2024-11-01/bmo
Earnings (Next)02-04 2025-02-04/amc
Inst Owners104.89%
Inst Owner Change-2.24%
Ins Owners1.08%
Ins Owner Change-1.63%
Market Cap2.21B
Analysts74.74
Price Target124.27 (32.02%)
Short Float %6.94%
Short Ratio6.38
Dividend
Industry RankSector Rank
Dividend Yield 0.49%
Dividend Growth(5Y)8.58%
DP5.85%
Div Incr Years3
Div Non Decr Years14
Ex-Date11-13 2024-11-13 (0.12)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-8.87%
Min EPS beat(2)-11.93%
Max EPS beat(2)-5.81%
EPS beat(4)1
Avg EPS beat(4)-5.53%
Min EPS beat(4)-14%
Max EPS beat(4)9.61%
EPS beat(8)2
Avg EPS beat(8)-2.98%
EPS beat(12)6
Avg EPS beat(12)3.81%
EPS beat(16)10
Avg EPS beat(16)8.84%
Revenue beat(2)1
Avg Revenue beat(2)-1.19%
Min Revenue beat(2)-2.47%
Max Revenue beat(2)0.08%
Revenue beat(4)1
Avg Revenue beat(4)-1.43%
Min Revenue beat(4)-2.47%
Max Revenue beat(4)0.08%
Revenue beat(8)1
Avg Revenue beat(8)-2.59%
Revenue beat(12)2
Avg Revenue beat(12)-2.42%
Revenue beat(16)5
Avg Revenue beat(16)-1.81%
PT rev (1m)-0.75%
PT rev (3m)-6.35%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-60.72%
EPS NY rev (1m)-1.49%
EPS NY rev (3m)-17.95%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-13.57%
Revenue NY rev (1m)-0.35%
Revenue NY rev (3m)-2.69%
Valuation
Industry RankSector Rank
PE 12.67
Fwd PE 11.8
P/S 0.52
P/FCF 27.15
P/OCF 6.2
P/B 1.69
P/tB 2.42
EV/EBITDA 5.07
EPS(TTM)7.43
EY7.89%
EPS(NY)7.98
Fwd EY8.47%
FCF(TTM)3.47
FCFY3.68%
OCF(TTM)15.19
OCFY16.14%
SpS181.88
BVpS55.72
TBVpS38.82
PEG (NY)N/A
PEG (5Y)0.82
Profitability
Industry RankSector Rank
ROA 8.02%
ROE 14.82%
ROCE 15.93%
ROIC 12.1%
ROICexc 13.58%
ROICexgc 18.22%
OM 6.53%
PM (TTM) 4.54%
GM 85.74%
FCFM 1.91%
ROA(3y)9.98%
ROA(5y)7.27%
ROE(3y)21.54%
ROE(5y)15.69%
ROIC(3y)13.45%
ROIC(5y)10.27%
ROICexc(3y)15.54%
ROICexc(5y)12.36%
ROICexgc(3y)22.24%
ROICexgc(5y)16.97%
ROCE(3y)17.71%
ROCE(5y)13.52%
ROICexcg growth 3Y11.82%
ROICexcg growth 5Y-5.87%
ROICexc growth 3Y7.61%
ROICexc growth 5Y-6.51%
OM growth 3Y14.12%
OM growth 5Y0.46%
PM growth 3Y22.21%
PM growth 5Y15.27%
GM growth 3Y2.85%
GM growth 5Y1.63%
F-Score7
Asset Turnover1.77
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 2.22
Debt/EBITDA 0.28
Cap/Depr 186.94%
Cap/Sales 6.45%
Interest Coverage 250
Cash Conversion 83.74%
Profit Quality 41.99%
Current Ratio 1.04
Quick Ratio 1.04
Altman-Z 4.18
F-Score7
WACC8.55%
ROIC/WACC1.41
Cap/Depr(3y)113.52%
Cap/Depr(5y)96.03%
Cap/Sales(3y)3.44%
Cap/Sales(5y)3.14%
Profit Quality(3y)87.76%
Profit Quality(5y)128.43%
High Growth Momentum
Growth
EPS 1Y (TTM)-5.71%
EPS 3Y34.87%
EPS 5Y15.4%
EPS Q2Q%-29%
EPS Next Y-23.45%
EPS Next 2Y0.48%
EPS Next 3Y11.25%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.88%
Revenue growth 3Y14.62%
Revenue growth 5Y7.43%
Sales Q2Q%-5.78%
Revenue Next Year-5.47%
Revenue Next 2Y-0.79%
Revenue Next 3Y2.08%
Revenue Next 5YN/A
EBIT growth 1Y61.62%
EBIT growth 3Y30.8%
EBIT growth 5Y7.93%
EBIT Next Year45.11%
EBIT Next 3Y23.98%
EBIT Next 5YN/A
FCF growth 1Y-74.96%
FCF growth 3Y-15.32%
FCF growth 5Y-14.83%
OCF growth 1Y-18.18%
OCF growth 3Y16.07%
OCF growth 5Y4.76%